Read this company snapshot
Daily valuation snapshot
Tandem Diabetes Care, Inc.: source evidence dated 2026-10-09.
- Daily close (USD)
- $16.11
- Market capitalization (USD)
- $1,120,912,969.77
- Price / earnings (TTM)
- Not reported
- Price / book
- 8.6
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TNDM in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TNDM in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing TNDM with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $16.11 |
| Market capitalization (USD) | $1,120,912,969.77 |
| Price / earnings (TTM) | Not reported |
| Price / book | 8.6 |
No matching rows. Clear the filter to see all records.
Read TNDM's valuation metrics
Company size
Tandem Diabetes Care, Inc.'s recorded market capitalization is $1,120,912,969.77. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
TNDM's recorded price-to-book ratio is 8.6. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Tandem Diabetes Care, Inc. with Aurora
Use the snapshot above to ask a specific question about TNDM. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow TNDM's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.